首页|美沙拉嗪联合双歧杆菌三联活菌治疗溃疡性结肠炎患者的疗效分析

美沙拉嗪联合双歧杆菌三联活菌治疗溃疡性结肠炎患者的疗效分析

扫码查看
目的 探讨美沙拉嗪联合双歧杆菌三联活菌治疗溃疡性结肠炎的临床疗效.方法 选取舟山市妇幼保健院收治的溃疡性结肠炎(UC)患者72例,分为实验组和对照组,每组36例.对照组口服美沙拉嗪治疗,实验组在口对照组基础上联合双歧杆菌三联活菌治疗.检测2组患者血清分离后,静脉血中血清超氧化物歧化酶(SOD)、丙二醛(MDA)及反应蛋自(CRP)浓度水平.随访观察并记录2组病症改善情况、临床疗效及治疗后不良反应发生情况.结果 治疗后,2组患者血清MDA、CRP浓度明显降低,SOD浓度水平明显升高,差异均有统计学意义(P<0.05).治疗后,实验组血清中MDA、CRP浓度水平低于对照组,SOD浓度水平明显高于对照组,差异均有统计学意义(P<0.05).治疗后,2组患者腹痛、腹泻、黏液血便症状显著改善,且实验组腹痛、腹泻及黏液血便症状发生率低于对照组;实验组不良反应发生率明显低于对照组,差异均有统计学意义(P<0.05).结论 美沙拉嗪内口服联合双岐杆菌三联活菌治疗溃疡性结肠炎临床疗效显著,能降低MDA、CRP浓度程度,增高SOD活性.
Effect of mesalazine combined Bifidobacterium triple viable in the treatment of ulcerative colitis
Objective To explore the beauty of mesalazine combined with Bifid Triple viable bacilli clinical efficacy in the treatment of ulcerative colitis.Methods 72 patients with ulcerative colitis ( UC) in zhoushan maternal and child health hospital were selected and divided into experimental group and control group,36 cases in each group.The control group was treated with oral administration of melamine and the experimental group was treated with Bifidobacterium triple live bacteria on the basis of oral control group.The levels of superoxide dismutase (SOD), malondialdehyde (MDA) and reactive protein ( CRP) concentration in serum of patients were detected.Follow up observation and record of the experimental group and the control group to improve the symptoms, clinical efficacy and adverse reactions after treatment.Results After treatment,serum MDA, CRP concentrations of the two groups were significantly lower than those before treatment concentration, SOD concentration was significantly increased, the differences were statistically significant (P<0.05) , serum MDA, CRP levels in the experimental group were lower than the control group, the concentration of SOD was significantly higher than control group,the differences were statistically significant (P<0.05) .After treatment, abdominal pain, diarrhea, mucus and blood stool symptoms of two groups were significantly improved compared with before treatment, abdominal pain, diarrhea and bloody mucus symptoms in the experimental group were lower than the control group(P<0.05).Incidence of adverse reactions in the experimental group was significantly lower than the control group, the differences were statistically significant (P<0.05).Conclusion The efficacy of oral administration of methadiazole in combination with Bifidobacterium triple live bacteriain the treatment of ulcerative colitis is significant, Can reduce MDA, CRP concentration, increased SOD activity.

mesalazineBifidobacterium triple live bacteriaulcerative colitis

陈伟、曹春宇、黎运呈

展开 >

舟山市妇幼保健院消化内科,浙江舟山316004

美沙拉嗪 双歧杆菌三联活菌 溃疡性结肠炎

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(3)
  • 50
  • 4